An evaluation of 100 patients at an NHS clinic in the UK has...
- Haemoglobin spray could cut NHS chronic wound care costs, study finds
- Dreem team: insomnia therapy goes hi-tech
- Robotic thread could treat stroke and other brain blockages
- Snooze, you lose: the devices helping to understand the science of sleep
- The hesitancy hurdle: how tech can improve adult vaccination rates
Researchers find blood test to identify rare breast cancer mutations
Researchers from Cancer Research UK have found that a blood test could quickly identify rare mutations in patients with advanced breast cancer.
Haemoglobin spray could cut NHS chronic wound care costs, study finds
An evaluation of 100 patients at an NHS clinic in the UK has demonstrated savings in chronic would care costs with the use of Granulox, a haemoglobin spray that binds oxygen from the atmosphere and diffuses it into the wound to promote faster healing.
PerkinElmer’s screening kit for DMD in newborns gets FDA approval
The US Food and Drug Administration (FDA) has granted marketing approval for PerkinElmer’s GSP Neonatal Creatine Kinase-MM kit, a newborn screening test for Duchenne Muscular Dystrophy (DMD).
Israeli health tech firms merge to advance AI-powered biomarkers
Israel-based artificial intelligence (AI) startups Beyond Verbal and Healthymize, which both make diagnoses through voice analyses, have merged operations to create an entity, Vocalis Health.
Cochlear obtains FDA approval for bone conduction implant
Australia-based Cochlear has received clearance from the US Food and Drug Administration (FDA) for its Osia 2 implantable bone conduction hearing system.
Beta Bionics receives breakthrough designation for blood sugar device
Beta Bionics has secured breakthrough device designation status from the US Food and Drug Administration (FDA) for its iLet Bionic Pancreas System.
Roche obtains CE mark for blood glucose monitoring app
Roche has secured CE mark for its smartphone app that allows users to measure blood glucose level without the need of a meter.
Nihon Kohden introduces new vital signs monitoring device
US-based Nihon Kohden has introduced a new portable vital signs monitoring tool with customisable early warning scoring.
FDA approves Aptar’s acute repetitive seizures treatment device
The US Food and Drug Administration (FDA) has approved Aptar Group’s Unidose Liquid System to treat acute repetitive seizures in those with epilepsy.
C2N Diagnostics reports positive results for Alzheimer’s blood test
C2N Diagnostics has reported positive results from the clinical study that evaluated APTUS-Aβ blood test’s accuracy in detecting pathology of Alzheimer’s disease in the brain.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.